Tag Archives: Hidradenitis Suppurativa

Humira approved in Japan for treatment of Hidradenitis Suppurativa

New Delhi: AbbVie, a research-based global biopharmaceutical company headquartered in US, and Eisai, a leading global research & development-based pharmaceutical company headquartered in Japan, on Thursday announced that they have received approval for an additional indication of Humira (generic name: adalimumab), a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa (HS).

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , | Leave a comment